8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Hydrogen Sulfide Improves Endothelial Dysfunction via Downregulating BMP4/COX-2 Pathway in Rats with Hypertension

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims. We object to elucidate that protective effect of H 2S on endothelium is mediated by downregulating BMP4 (bone morphogenetic protein 4)/cyclooxygenase- (COX-) 2 pathway in rats with hypertension. Methods and Results. The hypertensive rat model induced by two-kidney one-clip (2K1C) model was used. Exogenous NaHS administration (56  μmol/kg/day, intraperitoneally once a day) reduced mean arterial pressure (MAP) of 2K1C rats from 199.9 ± 3.312 mmHg to 159.4 ± 5.434 mmHg, while NaHS did not affect the blood pressure in the Sham rats and ameliorated endothelium-dependent contractions (EDCs) of renal artery in 2K1C rats. 2K1C reduced CSE level twofold, decreased plasma levels of H 2S about 6-fold, increased BMP4, Nox2, and Nox4 levels 2-fold and increased markers of oxidative stress MDA and nitrotyrosine 1.5-fold, upregulated the expression of phosphorylation-p38 MAPK 2-fold, and increased protein levels of COX-2 1.5-fold, which were abolished by NaHS treatment. Conclusions. Our results demonstrate that H 2S prevents activation of BMP4/COX-2 pathway in hypertension, which may be involved in the ameliorative effect of H 2S on endothelial impairment. These results throw light on endothelial protective effect of H 2S and provide new target for prevention and therapy of hypertension.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase.

          Studies of nitric oxide over the past two decades have highlighted the fundamental importance of gaseous signaling molecules in biology and medicine. The physiological role of other gases such as carbon monoxide and hydrogen sulfide (H2S) is now receiving increasing attention. Here we show that H2S is physiologically generated by cystathionine gamma-lyase (CSE) and that genetic deletion of this enzyme in mice markedly reduces H2S levels in the serum, heart, aorta, and other tissues. Mutant mice lacking CSE display pronounced hypertension and diminished endothelium-dependent vasorelaxation. CSE is physiologically activated by calcium-calmodulin, which is a mechanism for H2S formation in response to vascular activation. These findings provide direct evidence that H2S is a physiologic vasodilator and regulator of blood pressure.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?

            Rui Wang (2002)
            Bearing the public image of a deadly "gas of rotten eggs," hydrogen sulfide (H2S) can be generated in many types of mammalian cells. Functionally, H2S has been implicated in the induction of hippocampal long-term potentiation, brain development, and blood pressure regulation. By acting specifically on KATP channels, H2S can hyperpolarize cell membranes, relax smooth muscle cells, or decrease neuronal excitability. The endogenous metabolism and physiological functions of H2S position this gas well in the novel family of endogenous gaseous transmitters, termed "gasotransmitters." It is hypothesized that H2S is the third endogenous signaling gasotransmitter, besides nitric oxide and carbon monoxide. This positioning of H2S will open an exciting field-H2S physiology-encompassing realization of the interaction of H2S and other gasotransmitters, sulfurating modification of proteins, and the functional role of H2S in multiple systems. It may shed light on the pathogenesis of many diseases related to the abnormal metabolism of H2S.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques.

              In the present study, we examined the expression of regulators of bone formation and osteoclastogenesis in human atherosclerosis because accumulating evidence suggests that atherosclerotic calcification shares features with bone calcification. The most striking finding of this study was the constitutive immunoreactivity of matrix Gla protein, osteocalcin, and bone sialoprotein in nondiseased aortas and the absence of bone morphogenetic protein (BMP)-2, BMP-4, osteopontin, and osteonectin in nondiseased aortas and early atherosclerotic lesions. When atherosclerotic plaques demonstrated calcification or bone formation, BMP-2, BMP-4, osteopontin, and osteonectin were upregulated. Interestingly, this upregulation was associated with a sustained immunoreactivity of matrix Gla protein, osteocalcin, and bone sialoprotein. The 2 modulators of osteoclastogenesis (osteoprotegerin [OPG] and its ligand, OPGL) were present in the nondiseased vessel wall and in early atherosclerotic lesions. In advanced calcified lesions, OPG was present in bone structures, whereas OPGL was only present in the extracellular matrix surrounding calcium deposits. The observed expression patterns suggest a tight regulation of the expression of bone matrix regulatory proteins during human atherogenesis. The expression pattern of both OPG and OPGL during atherogenesis might suggest a regulatory role of these proteins not only in osteoclastogenesis but also in atherosclerotic calcification.
                Bookmark

                Author and article information

                Journal
                Oxid Med Cell Longev
                Oxid Med Cell Longev
                OMCL
                Oxidative Medicine and Cellular Longevity
                Hindawi Publishing Corporation
                1942-0900
                1942-0994
                2016
                23 August 2016
                : 2016
                : 8128957
                Affiliations
                1Department of Physiology, Hebei Medical University, Shijiazhuang 050017, China
                2Hebei Key Laboratory of Animal Science, Hebei Medical University, Shijiazhuang 050017, China
                3Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease, Shijiazhuang 050017, China
                4Key Laboratory of Vascular Medicine of Hebei Province, Shijiazhuang 050017, China
                Author notes

                Academic Editor: Guangdong Yang

                Author information
                http://orcid.org/0000-0002-2876-0007
                http://orcid.org/0000-0001-7891-9453
                http://orcid.org/0000-0001-7777-9700
                http://orcid.org/0000-0002-9571-0843
                http://orcid.org/0000-0001-6762-2929
                http://orcid.org/0000-0003-2206-8308
                http://orcid.org/0000-0002-3282-056X
                Article
                10.1155/2016/8128957
                5011526
                27642495
                6b3c07d3-909d-4617-bf4a-430ce8611f8b
                Copyright © 2016 Lin Xiao et al.

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 28 April 2016
                : 26 June 2016
                Funding
                Funded by: National Natural Science Foundation of China
                Award ID: 31171098
                Funded by: Specialized Research Fund for the Doctoral Program of Higher Education of China
                Award ID: 20121323110008
                Funded by: Hebei Province for Innovation Talents Support Plan
                Award ID: LJRC017
                Funded by: Key Medical Guidance Topics of Health Department
                Award ID: 20130143
                Funded by: Education Foundation of Hebei Province of China
                Award ID: QN2016144
                Categories
                Research Article

                Molecular medicine
                Molecular medicine

                Comments

                Comment on this article